Accera Targets Metabolism In Alzheimer’s
This article was originally published in The Pink Sheet Daily
Executive Summary
Prescription medical food Axona set to debut in U.S. first quarter of 2009.
You may also be interested in...
Deals Of The Week: Express Scripts/Walgreens, Par/TPG, Amicus/GSK
Following the clinical trial failure of cancer candidate saridegib, Infinity takes back partnered assets from Purdue and plans to go it alone in the PI3K space.
Switzerland's Shield Therapeutics Raises $12M To Conduct Phase III Trials On Oral Iron Deficiency Product
Oral iron deficiency therapy to advance into Phase III this year on the back of $12 million fund raising for Swiss minnow, Shield Therapeutics.
Switzerland's Shield Therapeutics Raises $12M To Conduct Phase III Trials On Oral Iron Deficiency Product
Oral iron deficiency therapy to advance into Phase III this year on the back of $12 million fund raising for Swiss minnow, Shield Therapeutics.